NIB stock sees AUD 97.6 million travel sale completed

Published on 10/08/2026 at 01:40 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

NIB stock's FY26 underlying operating profit rose 9.1 percent to AUD 260.9 million on August 24, 2026. The final dividend totaled 34.0 cents per share.

NIB, AU000000NHF0, Illustration mit AI erstellt.

NIB stock (ISIN AU000000NHF0) was last at AUD 6.45 on ASX on October 7, 2026 at 10:19 a.m. AEDT, up 0.16 percent from AUD 6.44. The company completed its travel insurance exit for AUD 97.6 million, sharpening its focus on health insurance.

Travel exit releases AUD 97.6 million

According to nib on October 1, 2026, the group completed the sale of its Australian and New Zealand travel insurance operations to Allianz Partners and its World Nomads business to International Medical Group.

The transactions delivered AUD 97.6 million in cash consideration, with up to AUD 10 million of deferred consideration eligible in fiscal year 2028. The company also continued distributing nib-branded travel insurance in Australia and New Zealand under a long-term partnership with Allianz Partners.

FY26 profit mix stays uneven

For the fiscal year ended June 30, 2026, group underlying revenue increased 6.2 percent to AUD 3.82 billion, while underlying operating profit rose 9.1 percent to AUD 260.9 million, according to Kapitales Research on September 21, 2026.

The earnings mix was less uniform: net profit after tax declined 5.9 percent to AUD 186.9 million, partly because of lower investment income and higher one-off acquisition and integration expenses. Australian residents health insurance remained the largest contributor, but its underlying operating profit fell 9.6 percent to AUD 187.9 million as claims costs increased.

Stock remains below yearly high

NIB stock traded 16.6 percent below its 52-week high of AUD 7.73 and 11.4 percent above its 52-week low of AUD 5.79 on October 7, 2026. Market capitalization stood at AUD 3.1 billion, while volume reached 885,987 shares.

For investors, the completed divestment changes the portfolio mix more than the daily quote: travel proceeds support capital management, while health insurance claims costs remain the key operating counterweight.